Form D · Biotechnology
SynGen Inc.
Sacramento, CA · CIK 0001547876
Offering snapshot reported Jun 26, 2017 · SEC filing
- Reported sold
- $400K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2017 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Apr 21, 2017 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Mar 24, 2017 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Feb 27, 2017 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jan 19, 2017 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Nov 28, 2016 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| Jul 26, 2016 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| May 10, 2016 | Initial | $1,563,422 | No comparison | 3 | SEC filing |
| Feb 10, 2016 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Jun 8, 2015 | Initial | $2,250,000 | No comparison | 2 | SEC filing |
| Sep 22, 2014 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Jan 7, 2014 | Initial | $0 | No comparison | 1 | SEC filing |
| Jul 10, 2013 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
| Jul 10, 2013 | Amendment | $2,000,000 | $0vs Apr 24, 2012 | 2 | SEC filing |
| Apr 24, 2012 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-289408
Source: Form D, filed Jun 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Barry | Director |
| Philip H. Coelho | Executive |
| William Gerber | Director, Executive |
| Carl Goldfischer | Director |
| Woodrow A. Myers, Jr. | Director |
| Chuck Novak | Executive |
| Vic Schmitt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Howe Avenue Suite 185 N
Sacramento, CA, 95825
Sacramento, CA, 95825